熱門資訊> 正文

DBV Technologies GAAP每股收益为-1.05美元

2026-03-27 17:16

DBV Technologies press release (DBVT): FY GAAP EPS of -$1.05.
On December 31, 2025, DBV held $194.2 million in cash and cash equivalents compared to $32.5 million of cash and cash equivalents on December 31, 2024.
Net cash used for operating activities was $121.2 million and $104.5 million for the years ended December 31, 2025, and 2024, respectively.

More on DBV Technologies

DBV Technologies S.A. (DBVT) Presents at American Academy of Allergy, Asthma & Immunology (AAAAI) 2026 Annual Meeting - Slideshow
Seeking Alpha’s Quant Rating on DBV Technologies
Historical earnings data for DBV Technologies
Financial information for DBV Technologies

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。